Close X
Wednesday, November 13, 2024
ADVT 
International

Making 'huge push' to process as many visa applications in India: US

Darpan News Desk IANS, 16 Jun, 2023 01:16 PM
  • Making 'huge push' to process as many visa applications in India: US

Photo courtesy of IANS and IStock

New York, June 16 (IANS) Consular teams have been making a huge push to process as many visa applications as possible in India, which remains the US government's top priority, State Department spokesperson Matthew Miller said in a news briefing.

"The consular teams have been making a huge push to process as many visa applications as possible in India, including in those visa categories that are key to the bilateral relationship," Miller said on Thursday in response to a question on what can Indian can expect from the US on diplomacy, immigration and visa issues ahead of Prime Minister Narendra Modi's visit.

"This is a top priority for our government. We know that there is more work that we can do, and we are working hard to do it," he said.

Miller's remarks came just after US Ambassador to India Eric Garcetti said that consular teams in Chennai, Kolkata, Hyderabad, Mumbai and New Delhi are on track to process the highest number of Indian student visa applications in history this year.

"This summer, we're on track to process the highest number of Indian student visa applications in the history of this Mission," Garcetti had said in a tweet praising his consular teams.

Garcetti had said that one out of every five US student visas was issued in India in 2022 -- more than the proportion of the Indian population in the world.

In 2022, Indians were issued the highest numbers of H&L employment visas (65 per cent) and F1 student visas (17.5 per cent) worldwide.

Miller said that White House will be making further announcements about Modi's visit in the coming days leading up to the trip next week.

The State Department spokesperson told reporters that the US looks forward to closely working with India on most vital priorities, which includes ensuring a free and open Indo-Pacific.

"I will say generally our partnership with India is one of our most consequential relationships. We look closely with India on -- we work closely with India on our most vital priorities. They play a crucial role in ensuring a free and open Indo-Pacific that is connected, prosperous, secure, and resilient," Miller said.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK